GlassScriptPhysician profile
Vandana Hoon
NPI 1356314686
$1,413.18
in general payments reported to CMS, 2019-2025
16 companies · $24.21 in 2025
The $24.21 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $62.42 · 2021: $588 · 2022: $27.33 · 2023: $338 · 2024: $145 · 2025: $24.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $460.60 | 2021 | |
| Amgen INC. | $186.47 | 2019-2023 | Lumakras |
| Boston Scientific Corporation | $144.89 | 2024 | |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $102.81 | 2023 | Trident Specimen Radiography System |
| Biohaven Pharmaceuticals, INC. | $73.58 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $55.64 | 2019-2023 | Lynparza |
| Daiichi Sankyo INC. | $52.72 | 2023-2025 | Enhertu |
| Merck Sharp & Dohme LLC | $44.25 | 2019-2021 | |
| Octapharma USA, INC. | $42.27 | 2019 | |
| Genentech USA, INC. | $34.49 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $25.62 | 2019 | |
| Myriad Genetic Laboratories, INC. | $24.89 | 2023 | Precisetumor |
| E.R. Squibb & Sons, L.L.C. | $14.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.82 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vandana Hoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.